Trials / Completed
CompletedNCT05577065
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
A Randomised, Double-blinded, Placebo-controlled, Parallel Study, to Assess the Effect of a Probiotic on the Incidence, Duration and Severity of Upper Respiratory Tract Infections in Healthy Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- The Archer-Daniels-Midland Company · Industry
- Sex
- All
- Age
- 2 Years – 8 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the efficacy of a single strain probiotic on the incidence, duration and severity of upper respiratory tract infections in healthy, school-age children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | Single strain probiotic in the form of a sachet with a daily dose of 3E+9 Colony Forming Unit (CFU) per day for 26 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Matching placebo in the form of a sachet once daily for 26 weeks |
Timeline
- Start date
- 2023-01-30
- Primary completion
- 2024-03-13
- Completion
- 2024-03-13
- First posted
- 2022-10-13
- Last updated
- 2025-04-09
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT05577065. Inclusion in this directory is not an endorsement.